MedPath

Pre-Op MRI on Margin Status for Transoral Robotic Surgery for HPV+ Tonsillar Squamous Cell Carcinoma

Not Applicable
Not yet recruiting
Conditions
Human Papilloma Virus Related Carcinoma
Tonsillar Squamous Cell Carcinoma
Registration Number
NCT07060261
Lead Sponsor
Case Comprehensive Cancer Center
Brief Summary

This prospective research study aims to see if pre-operative MRI can predict the margin status after transoral robotic surgery (TORS) for human papillomavirus positive (HPV+) tonsillar squamous cell carcinoma (SCC). The pre-operative MRI will have a standard MR neck without and with contrast, with added axial T2 weighted sequence and T2 SPACE sequence through the tonsils. Three neuroradiologists will grade the thickness of the pharyngeal constrictor muscle (the muscle that surrounds the tonsils) on a five-point scale. The study will determine if the pre-operative MRI grading will correlate with positive, insecure (\<1mm), or secure (\>1mm) margin during TORS surgery for your HPV+ tonsillar SCC.

Detailed Description

There has been a marked increase in the incidence on oropharyngeal SCC in recent decades because of the rise of HPV+ disease1-3. Stage I or II tonsillar SCC can be treated by either surgery or radiation with similar good outcomes. For tumors treated surgically, transoral robotic surgery has replaced open surgery due to decreased morbidity and improved local control. It has been shown that margin status of 1.1mm of healthy tissue around the tumor is sufficient for adequate local control. However, approximately 8.1% of the time there is a positive or insecure margin, resulting in added adjuvant radiation and possibly chemotherapy, with increasing morbidity for each added treatment modality.

Therefore, there is a need to determine pre-operatively the chance of positive or insecure margin at surgery to avoid increased morbidity with added adjuvant treatment. Currently, the most commonly used imaging modality is computed tomography (CT) or magnetic resonance imaging (MRI), but this is to rule out absolute contraindications such as internal carotid artery encasement, involvement of the mandibular periosteum, prevertebral fascia/musculature, or masticator space musculature. Recently, a retrospective study used a novel five-point grading scale (1, normal constrictor; 2, bulging constrictor; 3, thinning constrictor; 4, obscured constrictor; and 5, tumor protrusion into the parapharyngeal fat) to evaluate the pharyngeal constrictor muscle, showing that higher scores with obscured constrictor or tumor protrusion into the parapharyngeal fat resulted in increased risk of positive or insecure margin. Given this, there is need for a prospective study to estimate the accuracy of the five-point MRI score with respect to distinguishing patients who go onto have secure surgical margins versus patients who go on to have insecure/positive surgical margins including surgical report of violation of anatomic boundaries (pharyngeal constrictor muscle)

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Adults ≥ 18 years of age.
  2. Participants being considered for TORS for HPV+ tonsillar SCC.
Exclusion Criteria
  1. Participants < 18 years of age.
  2. Participants who cannot provide informed consent.
  3. Participants who do not wish to participate.
  4. Vulnerable populations, including but not limited to cognitively impaired persons, pregnant women, and students or house staff under the direct supervision of the investigator.
  5. Participants in whom MRI is contraindicated.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Accuracy as assessed by 5-point MRI scorePerioperative

Accuracy will be summarized using the area under the receiver operating characteristics curve (AUC)

Secondary Outcome Measures
NameTimeMethod
Number of Grade 5 cases missed by pre-operative CT versus pre-operative MRIPerioperative
Percentage of patients who received adjuvant treatment, stratified by MRI grade.Perioperative
Percentage of participants who received adjuvant therapy, stratified by MRI grade.Perioperative
Predictive value of tumor size and diffusion/perfusion MRI parameters for post-operative surgical margin statusPerioperative

Trial Locations

Locations (1)

Case Comprehensive Cancer Center, Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Case Comprehensive Cancer Center, Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States
Lee Jonathan, MD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.